Navigation Links
Patients and their doctors have different perceptions about HIV and its treatment

According to results of a nation-wide study published in the latest issue of SAGE Publications' Journal of the International Association of Physicians in AIDS Care (JIAPAC), HIV positive patients and their doctors have very different views about the disease and how it's treated.

The study uncovered differences of opinion between patients and physicians about the initiation of treatment, the various goals of treatment, and even about whether or not the patient understands the doctors' explanations. These and other gaps in perception were revealed in the JIAPAC peer-reviewed article, "State of HIV Treatment: Results of IAPAC Surveys of HIV-Positive Patients and HIV-Treating Physicians in the United States."

The article explores the research findings about the attitudes of more than 500 HIV-positive patients and HIV-treating physicians regarding satisfaction with current treatment options, treatment side effects, patient-physician relationships, the importance of looking healthy, and other aspects related to HIV treatment.

"While the surveys highlighted many similar views between physicians and patients on issues such as treatment goals and satisfaction with currently available antiretroviral drugs," said José M. Zuniga, IAPAC President/CEO and the author of the JIAPAC article, "it is clear that more candid dialogue is needed to ensure a satisfactory treatment experience for people living with HIV/AIDS."


'"/>

Source:SAGE Publications


Page: 1

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs
3. Emory Eye Center Implants Its First Retinal Chips In Patients With Retinitis Pigmentosa
4. Implanted Devices Detect High-Risk Heart Failure Patients
5. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
6. Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients
7. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
8. Single-donor Islet Transplantation Procedure Shows Promise For Patients With Type 1 Diabetes
9. IMF Launches World’s First DNA Database for Myeloma Patients
10. Patients now surviving once-fatal immune disease
11. Patients to benefit from novel technology revolutionizing high-speed molecular imaging
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/6/2017)...  Delta ID Inc., a leader in consumer-grade iris ... at CES® 2017. Delta ID has collaborated with Gentex ... use of iris scanning as a secure, reliable and ... a car, and as a way to elevate the ... Delta ID and Gentex will demonstrate (booth #7326 LVCC) ...
(Date:12/22/2016)... MOUNTAIN VIEW, Calif. , Dec. 20, 2016  As ... all levels, 23andMe, the leading personal genetics company, recently released ... Only Me . The book focuses on the topics ... the Next Generation Science Standards (NGSS) taught in elementary school ... the second in a series by illustrator Ariana Killoran ...
(Date:12/19/2016)... 19 de diciembre de 2016  Mosaic Biomedicals SL anunció hoy ... de MSC-1, un anticuerpo humanizado que se espera comenzar a utilizar ... múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el primer ... leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos tumores ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... 2017  Market Research Future has a half cooked research report ... is growing rapidly and expected to reach USD 450 Million by ... ... Market has been assessed as a swiftly growing market and expected ... the coming future. There has been a tremendous growth in the ...
(Date:1/19/2017)... -- WuXi AppTec, a leading global pharmaceutical, biotechnology ... today announced that it has acquired HD Biosciences ... contract research organization (CRO). After completion of acquisition, ... WuXi, and will continue to focus on growing ... acquisition will further strengthen WuXi,s R&D capability from ...
(Date:1/19/2017)... ... January 19, 2017 , ... Genedata, ... (R&D), today announced the launch of Data Science Services , offering ... evolving field of precision medicine. , Data Science Services allows pharmaceutical ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, ... Altimmune, Inc., a privately-held immunotherapeutics company targeting infectious ... agreement for the merger of PharmAthene and Altimmune ... Novartis Venture Fund, HealthCap, Truffle Capital and Redmont ... and diversified immunotherapeutics company with four clinical stage ...
Breaking Biology Technology: